Stocks making the biggest moves premarket: Walgreens, Baidu, Novavax and others

Stocks making the biggest moves premarket: Walgreens, Baidu, Novavax and others


Check out the companies making headlines before the bell:

Walgreens (WBA) – The drug store operator reported an adjusted quarterly profit of $1.59 per share, 19 cents above estimates, with revenue also topping Wall Street forecasts. Comparable pharmacy sales rose 7.3%, helped by demand for Covid vaccines. Walgreens shares initially rose in the premarket but lost their gains and dipped negative.

Baidu (BIDU) – Baidu lost 2.2% in premarket trading after the SEC added the search engine company to its list of U.S.-traded China stocks that could be delisted if they don’t allow American regulators to review three years’ worth of financial audits. Online entertainment company iQYI (IQ) was also added to that list, with its shares sliding 6.6%.

Novavax (NVAX) – The drug maker’s shares gained 1.3% in premarket trading after it asked EU regulators to clear its Covid-19 vaccine for use in teenagers.

Advanced Micro Devices (AMD) – Advanced Micro Devices was downgraded to “equal weight” from “overweight” at Barclays, which points to cyclical risk in several different end markets for the semiconductor maker. AMD fell 2.2% in premarket action.

HP Inc. (HPQ), Dell Technologies (DELL) – Morgan Stanley downgraded both computer equipment makers, predicting companies will shift spending away from hardware due to macroeconomic uncertainty. HP was cut to “underweight” from “equal-weight” while Dell was cut to “equal-weight” from “overweight.” HP fell 4.5% in premarket trading, while Dell lost 2.6%.

Kinross Gold (KGC) – The gold mining company is in talks to sell a Russian mine to Russia-backed investment firm Fortiana Holdings, according to people familiar with the matter who spoke to The Wall Street Journal. It would be the first sale of an asset left behind in Russia by a Western company.

Amylyx Pharmaceuticals (AMLX) – An FDA panel voted against recommending the approval of an experimental ALS drug developed by Amylyx. The panel said study data failed to prove that the drug was effective in fighting the disease. Amylyx erased early premarket losses to rise by 2.5%.

Robinhood Markets (HOOD) – Robinhood won a favorable ruling in a Massachusetts case, with a judge deciding the state overstepped its authority in adopting a new fiduciary standard for brokerages operating in the state. The brokerage firm had been accused by regulators of encouraging its customers to take undue risks.

Expensify (EXFY) – Expensify tumbled 14.3% in the premarket after the online expense management company reported a lower-than-expected quarterly profit and issued a weaker-than-expected revenue forecast for the current quarter.



Source

The global M&A boom is rolling into 2026 as AI sparks deal frenzy — but cash is getting tight
Finance

The global M&A boom is rolling into 2026 as AI sparks deal frenzy — but cash is getting tight

Key Points Merger-and-acquisition activity roared back to life last year despite a sluggish start. Markets are betting that the surge will continue. While the appetite for deals remains strong, the pool of discretionary capital to fund them is historically thin. Source

Read More
Register now: Applications open for the World’s Top Fintech Companies 2026
Finance

Register now: Applications open for the World’s Top Fintech Companies 2026

Key Points CNBC and Statista chart the top fintech players from around the world, ranging from startups to Big Tech names. The World’s Top Fintech Companies has been expanded this year, with regulation tech — companies helping others meet their financial regulatory obligations — becoming its own segment. Applications are now open for companies to […]

Read More
PayPal pops nearly 7% on report fintech startup Stripe is weighing an acquisition
Finance

PayPal pops nearly 7% on report fintech startup Stripe is weighing an acquisition

Key Points Fintech startup Stripe is reportedly in early discussions to potentially buy PayPal. PayPal’s stock has plummeted over the last year as it faces slowing growth and mounting competition in the digital-payments market. Stripe hit a $159 billion valuation on Tuesday and said it was on track to reach an annual run rate of […]

Read More